申请人:ABBOTT LABORATORIES
公开号:EP0422666A2
公开(公告)日:1991-04-17
Compounds of the formula:
wherein n = 1 or 2; R₁ is lower alkoxy, lower alkyl, halo, ester, carbamate, or substituted amino; and R₂ is thienyl or furyl; or R₂ is
wherein R₃ and R₄ are independently selected from hydrogen, halo, hydroxy, methoxy, thioalkoxy, substituted amino and lower alkyl; and pharmaceutically acceptable salts thereof.
These compounds are useful as inhibitors of alpha-2-adrenergic receptors and for the treatment of glaucoma and/or controlling intraocular pressure.
式中的化合物
其中 n = 1 或 2;R₁ 是低级烷氧基、低级烷基、卤素、酯、氨基甲酸酯或取代氨基;以及 R₂ 是噻吩基或呋喃基;或 R₂ 是
其中 R₃ 和 R₄ 独立选自氢、卤素、羟基、甲氧基、硫代烷氧基、取代的氨基和低级烷基;及其药学上可接受的盐。
这些化合物可作为α-2-肾上腺素能受体的抑制剂,用于治疗青光眼和/或控制眼压。